Back to Search
Start Over
Investigating New Mechanisms of Acquired Resistance to Targeted Therapies: If You Hit Them Harder, Do They Get Up Differently?
- Source :
- Cancer Research. 80:25-26
- Publication Year :
- 2020
- Publisher :
- American Association for Cancer Research (AACR), 2020.
-
Abstract
- Targeted therapies have revolutionized treatment of several different types of cancers. However, in almost an invariable fashion, cancers eventually regrow in the presence of the targeted therapy, a phenomenon referred to as acquired resistance. In this issue of Cancer Research, Finn and colleagues demonstrate that modeling acquired resistance to MET tyrosine kinase inhibition in a MET-amplified gastric cancer cell line by a single, high exposure of the targeted therapy reveals clinically relevant acquired resistant mechanisms, which may be more faithful and comprehensive than the ones revealed through traditional ramp-up approaches. See related article by Finn et al., p. 79
- Subjects :
- 0301 basic medicine
Cancer Research
Carcinogenesis
business.industry
medicine.medical_treatment
Oncogenes
Drug resistance
Proto-Oncogene Proteins c-met
Bioinformatics
Targeted therapy
03 medical and health sciences
030104 developmental biology
0302 clinical medicine
Acquired resistance
Oncology
Drug Resistance, Neoplasm
Stomach Neoplasms
030220 oncology & carcinogenesis
Humans
Medicine
business
Gastric cancer cell
Subjects
Details
- ISSN :
- 15387445 and 00085472
- Volume :
- 80
- Database :
- OpenAIRE
- Journal :
- Cancer Research
- Accession number :
- edsair.doi.dedup.....4358f8b5ce9410034eba7e156d65cf23